Skip to search formSkip to main contentSkip to account menu

LY 544344

Known as: LY-544344, LY544344 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Group II metabotropic glutamate receptors (mGluR2/3) are suggested to modulate anxiety, arousal, and stress including autonomic… 
Review
2012
Review
2012
Review
2010
Review
2010
Metabotropic glutamate receptors (mGlu receptors) have emerged as new therapeutic targets for psychiatric disorders, such as… 
2010
2010
LY354740 is a potent mGlu2/3 agonist with a limited oral bioavailability. Its alanyl prodrug, LY544344, showed high affinity to… 
2009
2009
The limited oral bioavailability of the potent and selective group II metabotropic glutamate (mGlu) 2/3 receptor agonist, (1S,2S… 
Highly Cited
2008
Highly Cited
2008
LY354740, a potent and selective mGlu (metabotropic glutamate receptor)2/3 agonist, has shown efficacy in the treatment of… 
2007
2007
The peptidyl prodrug (1S,2S,5R,6S)-2-[(2′S)-(2-Amino)propionyl]a-minobicyclo[3.1.0.]hexen-2,6-dicarboxylic acid, also known as… 
Highly Cited
2006
Highly Cited
2006
Numerous studies have indicated that selective agonists of group II metabotropic glutamate (mGlu) receptors, such as LY354740… 
Highly Cited
2005
Highly Cited
2005
RationalePreclinical findings have repeatedly shown an anxiolytic-like action of agonists at metabotropic glutamate receptors… 
Review
2005
Review
2005
  • W. Danysz
  • IDrugs : the investigational drugs journal
  • 2005
  • Corpus ID: 21820180
Eli Lilly and Co is developing LY-544344, a prodrug of the metabotropic glutamate receptor 2/3 agonist LY-354740, for the…